These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30156164)

  • 1. Taxane Induced Cystoid Macular Edema: Case Report and Integrated Pathogenic Theory.
    Kanakis M; Georgalas I; Makatsoris T; Pharmakakis N
    Curr Drug Saf; 2019; 14(1):43-47. PubMed ID: 30156164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
    Dwivedi R; Tiroumal S
    Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiographically silent cystoid macular oedema secondary to paclitaxel therapy.
    Georgakopoulos CD; Makri OE; Vasilakis P; Exarchou A
    Clin Exp Optom; 2012 Mar; 95(2):233-6. PubMed ID: 22023333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired retinal pigment epithelium in paclitaxel-induced macular edema: A case report.
    Shih CH; Lee YC
    Medicine (Baltimore); 2018 Jun; 97(26):e11229. PubMed ID: 29952984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mystery of angiographically silent macular oedema due to taxanes.
    Kuznetcova TI; Cech P; Herbort CP
    Int Ophthalmol; 2012 Jun; 32(3):299-304. PubMed ID: 22484725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. En Face Optical Coherence Tomography and Optical Coherence Tomography Angiography Imaging of Taxane-Associated Cystoid Macular Edema.
    Sridhar J; Shahlaee A; Ehmann D; Samara WA; Rahimy E; Ho AC; Chiang A
    Ophthalmic Surg Lasers Imaging Retina; 2016 Feb; 47(2):176-9. PubMed ID: 26878452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomography characteristics of taxane-induced macular edema and other multimodal imaging findings.
    Perez JM; Teo K; Ong R; Maruyama-Inoue M; Freund KB; Tan ACS
    Graefes Arch Clin Exp Ophthalmol; 2020 Aug; 258(8):1607-1615. PubMed ID: 32458099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of cystoid macular edema associated with Paclitaxel chemotherapy.
    Ham DS; Lee JE; Kim HW; Yun IH
    Korean J Ophthalmol; 2012 Oct; 26(5):388-90. PubMed ID: 23060727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystoid macular edema without leakage secondary to nab-Paclitaxel (Abraxane): clinical experience with intravitreal bevacizumab.
    Rahman HT; Yeh S; Bergstrom CS
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):360-2. PubMed ID: 23061416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indocyanine green angiography findings of cystoid macular edema secondary to paclitaxel therapy.
    Nomi N; Ota M; Fukumura M; Nuno Y; Hatano M; Wakuta M; Yanai R; Kimura K
    Jpn J Ophthalmol; 2018 Mar; 62(2):163-167. PubMed ID: 29270811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of taxane-related cystoid macular edema after topical dorzolamide treatment: two case reports.
    Otsubo M; Kinouchi R; Kamiya T; Yoshida A
    J Med Case Rep; 2021 Jul; 15(1):355. PubMed ID: 34284818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nab-paclitaxel-induced cystoid macular edema in a patient with pre-existing optic neuropathy.
    Park E; Goldberg NR; Adams S
    Anticancer Drugs; 2016 Jul; 27(6):580-4. PubMed ID: 26982237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystoid macular edema and macular pigmentation associated with nab-Paclitaxel therapy.
    Haider A; Bababeygy SR; Lu SY
    Retin Cases Brief Rep; 2015; 9(3):220-2. PubMed ID: 25764317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystoid macular edema secondary to nanoparticle albumin-bound Paclitaxel therapy.
    Rahimy E; Sarraf D
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(2):187-9. PubMed ID: 23421925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cystoid macular edema secondary to albumin-bound paclitaxel therapy for pancreatic cancer].
    Ota S; Tanke G; Ito R; Hara K; Takada Y; Adachi K; Shimada Y; Itani T
    Nihon Shokakibyo Gakkai Zasshi; 2021; 118(3):272-278. PubMed ID: 33692262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Ocular Adverse Events With Taxane-Based Chemotherapy.
    Sodhi M; Yeung SN; Maberley D; Mikelberg F; Etminan M
    JAMA Ophthalmol; 2022 Sep; 140(9):880-884. PubMed ID: 35951320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral cystoid macular edema in a patient with taxane-based chemotherapy.
    Padrón Pérez N; Rubio Caso MJ; Arias Barquet L; Caminal Mitjana JM
    Can J Ophthalmol; 2013 Feb; 48(1):e3-4. PubMed ID: 23419309
    [No Abstract]   [Full Text] [Related]  

  • 18. Possibility of Müller Cell Dysfunction as the Pathogenesis of Paclitaxel Maculopathy.
    Nakao S; Ikeda Y; Emi Y; Ishibashi T
    Ophthalmic Surg Lasers Imaging Retina; 2016 Jan; 47(1):81-4. PubMed ID: 26731216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal imaging in paclitaxel-induced macular edema: the microtubule disfunction.
    Freitas-da-Costa P; Brandão E; Bragança T; Falcão-Reis F; Carneiro A
    Cutan Ocul Toxicol; 2015; 34(4):347-9. PubMed ID: 25597372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nab-Paclitaxel related cystoid macular edema.
    Di Pippo M; Di Staso F; De Ponte C; Fragiotta S; Abdolrahimzadeh S
    Clin Ter; 2022; 173(4):377-383. PubMed ID: 35857057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.